Introduction
The adrenal glands are the fourth most common site of distant metastases after lung, liver and bone (Willis, 1953) . The incidence of metastatic involvement of the adrenals is especially high in bronchogenic and breast carcinomas (Glomset, 1938) . On the other hand, clinical adrenal insufficiency secondary to metastases is very rare. In reviewing the literature we have found only 13 proven cases (Alpers et al., 1962; Butterly et al., 1952; Galloway & Perloff, 1960; Heath & Bergeuin, 1973; Herison, 1966; Rosenthal et al., 1978; Sahagian-Edwards & Holland, 1954; Vieweg et al., 1973; Zimm et al., 1981) . In all these patients the diagnosis was made by endocrinological tests, and in all of them except one (Zimm et al., 1981 ) the presence of bilateral adrenal metastases was confirmed at autopsy.
Here we present a case of Addison's disease secondary to metastatic involvement ofboth adrenal glands, diagnosed by laboratory methods and computed tomography (CT) scan, and confirmed at autopsy. A review of the relevant literature is presented.
Case report
A 45 year old man was admitted because of generalized weakness, fever, anorexia, nausea and vomiting.
Seven years previously the patient had undergone anterior resection of the colon for adenocarcinoma, followed by postoperative pelvic irradiation and treatment with 5-fluorouracil. Six years later the patient complained ofcough and weight loss and X-ray of the chest revealed a density in the right middle lobe with right pleural effusion. Bronchoscopy showed an endobronchial lesion which on biopsy was shown to be adenocarcinoma. A thoracotomy was performed in which a mass was found in the right middle lobe extending to the hilum and a liver mass was palpated through the diaphragm. The lung mass was not excised and biopsies confirmed the diagnosis of adenocarcinoma. Post-operatively the patient received another course of 5-fluorouracil.
On admission, 1 y after the thoracotomy, his temperature was 37.8°C, the heart rate was 80 beats/min, and the blood pressure 80/60 mm Hg. Diffuse hyperpigmentation of the skin was noted. Chest X-ray showed multiple metastases in the left lung. Cultures of blood, urine and throat were negative. Serum sodium and potassium were 130 mmol/l and 6.3 mmol/l, respectively. Serum ACTH level was 520 pg/ml (normal < 80 pg/ml). The basal concentrations of serum and urinary steroids were obtained and a Synacthen test was performed (Table I) .
In view of the recent complaints, the physical examination and the data shown in Table I , the Bullock & Hirst, 1953; Butterly et al., 1952; Galloway & Perloff, 1960; Guttman, 1930; Heath & Bergeuin, 1973; Herison, 1966; Hill & Wheeler, 1965; Rosenthal et al., 1978; Sahagian-Edwards & Holland, 1954; Vieweg et al., 1973; Zimm et al., 1981) (Table II) . The diagnosis of adrenal insufficiency was confirmed by measurements of steroid levels and ACTH stimulation tests in only 13 patients.
Addison's disease has also been reported in two patients suffering from Hodgkin's disease (Feinmann, et al., 1976) and malignant lymphoma (Osei et al., 1983) . These patients presented with Addison's disease and the adrenals were found to be infiltrated by the lymphoproliferative process.
Since the symptoms of extensive metastatic disease can be very similar to those of Addison's disease, one can accept as proven cases only those confirmed by endocrinological investigations.
The frequency ofmetastases to the adrenal glands in autopsy series of cancer patients ranges from 8.6 to 27% (Abrams et al., 1950; Glomset, 1938; Guttman, 1930; Willis, 1953) . As many as 58% of patients with breast carcinoma, 36% with lung cancer and 33% of patients with melanoma have been found at autopsy to have adrenal metastases (Glomset, 1938 , cited from Zimm etal., 1981 . Thus it is surprising that Addison's disease has only rarely been reported in cancer patients.
In a group of 566 cases of Addison's disease, metastatic carcinoma was the aetiological factor in 1 % (Guttman, 1930) . The following points must be kept in mind in order to understand the extremely low incidence of reported Addison's disease caused by metastases. In spite of the frequent involvement of the adrenal glands by the malignant process: (1) more than 80% of the total adrenal cortical tissue may be replaced by tumour without evidence of adrenal hypofunction (Cedermark & Sjoberg, 1981) ; (2) the symptoms of metastatic disease in its terminal stages coincide with many of the clinical symptoms of adrenal insufficiency (Hill & Wheeler 1965) ; (3) many treatment protocols include steroids that may mask the presence of Addison's disease. In some of these patients, even when the diagnosis ofAddison's disease is made, it might have been attributed to withdrawal of steroids. Bearing these points in mind, Addison's (Herison, 1966; Rosenthal et al., 1978; Sahagian-Edwards & Holland 1954) , Addison's disease was the presenting syndrome of the malignant process.
Since the response to replacement therapy is usually dramatic and results in significant palliation, it is important to consider Addison's disease in the cancer patient who has progressive anorexia, malaise and weight loss, especially if accompanied by hypotension, hyperpigmentation or electrolyte imbalance. Although the disease will be diagnosed infrequently, it is imperative to bear this diagnosis in mind and to perform the appropriate tests.
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